knowledge -WSS

knowledge

author：knowledge 2025-09-03 09:22:09 - browse：16

Is biotech back from its downturn? Can Nvidia solve biology? And is it wise to do a deal on a party bus?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recording from the J.P. Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024. We also talk about the latest twist in the Sarepta Therapeutics saga, a ubiquitous dealmaker, and life on the party circuit.

For more on what we cover, here’s the news on Sarepta; here’s more on Nvidia; here’s the story on Centerview; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Obesity now affects over 1 billion people worldwide, study finds

entertainment

WSS

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Scientists unlock the key to scar

Military medical care influenced by rank and race, new study finds

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Helping hospitals and community health centers plan for resilience

leisure time

knowledge

Wikipedia

Hollywood unions extend contract negotiations for actors

Solving academic medical centers' existential crisis

At least 13 dead in Texas as scorching temps continue

An inside look at PIPEs, biotech's buzzy new financing tool

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Psychedelics group wrestles with new pharma identity

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Medical leaders decry Supreme Court decision on affirmative action

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

entertainment

Case highlights the risks of experimental stem cell therapy

Scientists unlock the key to scar

Data integrity in scientific journals requires "effort" by publishers, institutions

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

An inside look at PIPEs, biotech's buzzy new financing tool

Solving academic medical centers' existential crisis

focus

leisure time

entertainment

knowledge